Diastolic heart failure: The forgotten manifestation of hypertensive heart disease

Current Hypertension Reports

Volumn 6, Issue 3, 2004, Pages 164-170

  Lapu Bula, Rigobert ^a   Ofili, Elizabeth ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRBESARTAN; RAMIPRIL; SPIRONOLACTONE;

AGE DISTRIBUTION; AGING; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DIASTOLE; DISEASE COURSE; DISEASE PREDISPOSITION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; MORTALITY; NONHUMAN; ORTHOSTATIC HYPOTENSION; REVIEW; SYMPTOMATOLOGY; SYSTOLE; TREATMENT PLANNING; UREMIA; CORONARY ARTERY ATHEROSCLEROSIS; HEART LEFT VENTRICLE HYPERTROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CORONARY ARTERIOSCLEROSIS; DIASTOLE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4644327145     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0064-y     Document Type: Review

References (78)

1. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35: 569-582.
2. Weber KT, Brilla GG, Janicki JS, et al.: Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol 1991, 86(Suppl 3):25-31.
3. Mandinov L, Eberli FR, Seiler C, Hess OM: Diastolic heart failure. Cardiovasc Res 2000, 45: 813-825.
4. Jessup M, Brozena S: Heart failure. N Engl J Med 2003, 348: 2007-2018.
5. Gaasch WH: Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994, 271: 1276-1280.
6. Zile MR, Gaassh WH, Carroll JD, et al.: Heart failure with a normal ejection fraction: Is the measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001, 104: 779-793.
7. Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1996, 275: 1557-1562.
8. Vasan RS: Diastolic heart failure: The condition exists and needs to be recognized, prevented, and treated [editorial]. BMJ 2003, 327: 1181-1182.
9. Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33: 1948-1955.
10. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26: 1565-1574.
11. Bonow RO, Udelson JE: Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med 1992, 117: 502-510.
12. Slama M, Susic D, Varagic J, Frohlich ED: Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002, 17: 368-373.
13. Cleland JG, Khand A, Clark A: The heart failure epidemic: Exactly how big is it? Eur Heart J 2001, 22: 623-626.
14. Cohen-Solal A: Diastolic heart failure: myth or reality?[editorial. Eur J Heart Fail 2002, 4: 395-400.
15. Petrie MC, Caruana L, Berry L, McMurray JJV: "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002, 87: 29-31.
16. Kawaguchi M, Hay I, Fetics B, Kass DA: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107: 714-720.
17. Burkhoff D, Maurer MS, Packer M: Heart failure with a normal ejection fraction: Is it really a disorder of diastolic function? [editorial]. Circulation 2003, 107: 656-658.
18. Caruana L, Petrie MC, Davie AP, McMurray JJV: Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or misdiagnosis? A prospective descriptive study. BMJ 2000, 321: 215-219.
19. Michalsen A, Konig G, Thimme W: Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998, 80: 437-441.
20. Arques S, Ambrosi P, Gelisse R, et al.: Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003, 42: 712-716.
21. de Simone G, Greco R, Mureddu GF, et al.: Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000, 101: 152-157.
22. Vasan RS, Levy D: Diastolic heart failure: no time to relax [editorial]. N Engl J Med 2001, 344: 56-59.
23. Gandhi SK, Powers JC, Nomeir AM, et al.. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344: 17-22.
24. van Kraaij DJW, van Pol PEJ, Ruiters AW, et al.. Diagnosing diastolic heart failure. Eur J Heart Fail 2002, 4: 419-430.
25. American Heart Association: 2000 heart and stroke statistical update. Dallas: American Heart Association; 2000.
26. Braunwald E: Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997, 377: 1360-1369.
27. Roger VL, Jacobson SJ, Weston SA, et al.: Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002, 136: 341-348.
28. Rosamond WD, Chambless LE, Folsom AR, et al.: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998, 339: 861-867.
29. Kannel WB, Ho K, Thom T: Changing epidemiological features of cardiac failure. Br Heart J 1994, 72(2 Suppl): S3-S9.
30. Schocken DD, Arrieta MI, Leaverton PE, Ross EA: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992, 20: 301-306.
31. Ramakrishnan S, Kothari SS, Bahl VK: Hypertensive heart failure. Indian Heart J 2003, 55: 21-26.
32. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157: 2413-2446.
33. Colhoun HM, Dong W, Poulter NR: Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998, 16: 747-752.
34. Marques-Vidal P, Tuomilehto J: Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid? J Hum Hypertens 1997, 11: 213-220.
35. Joffres MR, Ghadirian P, Fodor JG, et al.: Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997, 10: 1097-1102.
36. Chamontin B, Poggi L, Lang T, et al.: Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994. Am J Hypertens 1998, 11: 759-762.
37. Senni M, Tribouilloy CM, Rodeheffer RJ, et al.. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98: 2282-2289.
38. Philbin EF, Rocco TA, Lindenmuth NW, et al.: Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000, 109: 605-613.
39. Cohn JN, Johnson G: Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990, 81 (2 Suppl): III48-III53.
40. Sweitzer NK, Stevenson LW: Diastolic heart failure: miles to go before we sleep [editorial]. Am J Med 2000, 109: 83-685.
41. Dauterman KW, Massie BM, Gheorghiade M: Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 1998, 135: S310-S319.
42. Diller PM, Smucker DR, David B, Graham RJ: Congestive heart failure due to diastolic or systolic dysfunction: frequency and patient characteristics in an ambulatory setting. Arch Fam Med 1999, 8: 414-420.
43. Cohen-Solal A, Desnos M, Delahaye F, et al.: A national survey of heart failure in French hospitals. Eur Heart J 2000, 21: 763-769.
44. Topol EJ, Traill TA, Fortuin NJ: Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985, 312: 277-283.
45. Weinberg EO, Thienelt CD, Katz SE, et al.: Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999, 34: 264-273.
46. Lapu-Bula R, Ofili E, Oduwole A, et al.: Left ventricular structural and geometric relations to endothelium-dependent vasodilatory function: A clue to the hypertensive phenotype in African Americans? J Am Soc Echocardiogr 2001, 14: 492.
47. Lapu-Bula R, Ofili E, St Vrain J, et al.: Differential characterization of transmural distribution of myocardial blood flow and its relation to left ventricular structure in hypertensive patients: insights from dipyridamole contrast echocardiography. Circulation 2001, 104(Suppl): II-1954.
48. Cleland J, Swedberg K, Follath F, et al.: The Euroheart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003, 24: 442-463.
49. Lapu-Bula R, Robert A, De Kock M, et al.: Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemia dilated cardiomyopathy. Am J Cardiol 1999, 83: 728-734.
50. Vanoverschelde JLJ, Raphael DA, Robert A, Cosyns JR: Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol 1990, 15: 1288-1295.
51. Lapu-Bula R, Robert A, De Kock M, et al.: Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular diastolic filling. Am J Cardiol 1998, 82: 779-785.
52. Obert P, Stecken F, Courteix D, et al.: Effect of long-term intensive endurance training on left ventricular structure and diastolic function in prepubertal children. Int J Sports Med 1998, 19: 149-154.
53. Cuocolo A, Sax FL, Brush JE, et al.: Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990, 81: 978-986.
54. Doi R, Masuyama T, Yamamoto K, et al.: Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 2000, 18: 111-120.
55. Cingolani OH, Yang XP, Cavasin MA, Carretero OA: Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats. Hypertension 2003, 41: 249-254.
56. Hart CYT, Meyer DM, Tazelaar HD, et al.: Load versus humoral activation in the genesis of early hypertensive heart disease. Circulation 2001, 104: 215-220.
57. Vasan RS, Levy D: The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med 1996, 156:1789-1796.
58. Aeschbacher BC, Hutter D, Fuhrer J, et al.: Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001, 14: 106-113.
59. Mo R, Nordrehaug JE, Omvik P, Lung-Johansen P: The Bergen Blood Pressure study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press 1995, 4: 16-22.
60. Sinaiko AR: Hypertension in children. N Engl J Med 1996, 335: 1968-1973.
61. Mathew J, Sleight P, Lonn E, et al.: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. The Heart Outcomes Prevention Evaluation (HOPE) Investigators. Circulation 2001, 104: 1615-1621.
62. Lorell BH, Grossman W: Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol 1987, 9: 1189-1193.
63. European Study Group on Diastolic Heart Failure: How to diagnose diastolic heart failure. Eur Heart J 1998, 19: 990-1003.
64. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure. Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105: 1387-1393.
65. Vasan RS, Levy D: Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101: 2118-2121.
66. Banerjee F, Banerjee T, Khand A, et al.: Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002, 39: 138-141.
67. Little WC, Downes TR, Applegate RJ: Invasive evolution of left ventricular diastolic performance. Herz 1990, 15: 362-376.
68. Ommen SR, Nishimura RA: A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: Update 2003. Heart 2003, 89 (Suppl III : iii18-iii23.
69. Kudelka AM, Turner DA, Liebson PR, et al.: Comparison of cine magnetic resonance imaging and Doppler echocardiography for evaluation of left ventricular diastolic function. Am J Cardiol 1997, 80: 384-386.
70. Lubien E, DeMaria A, Krishnaswamy P, et al.: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105: 595-601.
71. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359: 995-1003.
72. Mitsunami K, Inoue S, Maeda K, et al.: Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 1998, 12: 469-474.
73. Angomachalelis N, Hourzamanis AI, Sideri S, et al.: Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection. Heart Vessels 1996, 11: 303-309.
74. Brilla CG: Aldosterone and myocardial fibrosis in heart failure. Herz 2000, 25:299-306.
75. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341: 709-717.
76. Betocchi S, Chiariello M: Effects of calcium antagonists on left ventricular structure and function. J Hypertens Suppl 1993, 11: S33-S37.
77. Cleland JGF, Tendera M, Adamus J, et al.: Peridopril for elderly people with chronic heart failure: the PEP-CHF study. Eur J Heart Fail 1999, 1: 211-217.
78. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362: 777-781.